The Methylerythritol Phosphate (MEP) Pathway for Isoprenoid Biosynthesis as a Target for the Development of New Drugs Against Tuberculosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|9|1325-1338

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.9, 2011-03, pp. : 1325-1338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The MEP Pathway: A New Target for the Development of Herbicides, Antibiotics and Antimalarial Drugs

By  

Current Pharmaceutical Design, Vol. 10, Iss. 19, 2004-07 ,pp. : 2391-2400

Bentham Science Publishers

Access to resources Recommend Favorite

New Approaches to Target the Mycolic Acid Biosynthesis Pathway for the Development of Tuberculosis Therapeutics

By  

Current Pharmaceutical Design, Vol. 20, Iss. 27, 2014-01 ,pp. : 4357-4378

Bentham Science Publishers

Access to resources Recommend Favorite

The Methylerythritol Phosphate Pathway and its Significance as a Novel Drug Target

By  

Current Pharmaceutical Biotechnology, Vol. 4, Iss. 4, 2003-08 ,pp. : 248-259

Bentham Science Publishers

Access to resources Recommend Favorite

New Tuberculosis Drugs in Development

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-03 ,pp. : 463-473

Bentham Science Publishers

Access to resources Recommend Favorite

Isoprenoid Biosynthesis of the Apicoplast as Drug Target

By  

Current Drug Targets, Vol. 8, Iss. 1, 2007-01 ,pp. : 3-13

Bentham Science Publishers

Access to resources Recommend Favorite